← Open Payments lookup

TARA PEMBERTON: Open Payments

NPI 1275803462 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$919 in 44 payments from 11 companies in 2025. Trend: 2023 $491 · 2024 $376 · 2025 $919

Food & beverage: $919
CompanyPaymentsAmount
CSL Behring17$300
GENZYME CORPORATION11$232
Regeneron Healthcare Solutions, Inc.3$94
Genentech USA, Inc.3$67
Novartis Pharmaceuticals Corporation4$63
Ionis Pharmaceuticals, Inc.1$38
BioCryst US Sales Co., LLC1$33
Takeda Pharmaceuticals U.S.A., Inc.1$28
Incyte Corporation1$26
AstraZeneca Pharmaceuticals LP1$21

Products named: DUPIXENT, Hizentra, Andembry, Xolair, Rhapsido, DAWNZERA, ORLADEYO, TAKHZYRO.

Industry payments across OR — which companies pay providers there.